Bionano Genomics, Inc. (BNGO) Institutional Ownership

Ownership Summary

According to SEC filings for the period ending December 2025, Bionano Genomics, Inc. (NASDAQ:BNGO) is held by 8 institutional firms.

• These investors collectively held 3.5% of the company's total shares outstanding in December 2025, down from 8.1% in September 2025.
• On a quarter-over-quarter basis, institutional holdings shifted by -7.97%, with a year-over-year a decrease of 84.91% in the count of filers.
• The latest 13F cycle for Bionano Genomics reveals that of 8 total investors, 2 funds grew their exposure, whereas 2 reduced theirs and 4 made no changes.
• The total number of shares held by institutions in Bionano Genomics decreased to 106.37K as of December 2025, a net change of down by 9.21K shares quarter on quarter, and down 6.00Mn shares year over year.
• With 82.31K shares, VANGUARD GROUP INC commands the largest institutional position in Bionano Genomics as of December 31, 2025, equating to 2.74% of the company.
• Among the most significant buyers of Bionano Genomics during December 2025 were VANGUARD GROUP INC (31.85K), R Squared Ltd (13.77K).
• Leading sellers of Bionano Genomics stock in December 2025 included UBS Group AG (54.82K), SBI Securities Co., Ltd. (10).
• The top 8 institutional holders of Bionano Genomics for the quarter ending December 2025 included VANGUARD GROUP INC (82.31K), R Squared Ltd (13.77K), UBS Group AG (9.06K), Concord Wealth Partners (1.00K), SBI Securities Co., Ltd. (224), Allworth Financial LP (6), TD Waterhouse Canada Inc. (4), Activest Wealth Management (3).